Ecdna News Today

CareDx (NASDAQ:CDNA – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares CareDx […]

Stephens reaffirmed their overweight rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the stock. CareDx Stock Up 3.0 % Shares of CDNA stock opened at $8.31 on Wednesday. The firm has a market cap of $430.29 […]

CareDx, Inc (NASDAQ:CDNA – Free Report) – Equities researchers at HC Wainwright lifted their FY2023 EPS estimates for shares of CareDx in a research note issued on Monday, January 29th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($1.76) per share for the year, up from their prior forecast of ($1.79). […]

By Chris Wack An unanimous verdict in favor of Natera in its patent infringement case against CareDx has been reached by a jury in the U.S. District Court...

By Chris Wack CareDX shares were down 7% at $8.43 after a jury in the U.S. District Court for the District of Delaware reached a unanimous verdict in favor...

CareDx, Inc (NASDAQ:CDNA – Get Free Report) shares traded down 5.8% during mid-day trading on Friday . The stock traded as low as $12.05 and last traded at $12.12. 225,925 shares were traded during trading, a decline of 79% from the average session volume of 1,065,182 shares. The stock had previously closed at $12.86. Analysts […]

CareDx (NASDAQ:CDNA – Get Free Report) and Todos Medical (OTCMKTS:TOMDF – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Analyst Ratings This is a summary of current […]

CareDx, Inc (NASDAQ:CDNA – Get Free Report) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 3,420,000 shares, a decline of 12.1% from the November 15th total of 3,890,000 shares. Based on an average daily trading volume, of 1,070,000 shares, the days-to-cover ratio […]

By Chris Wack Natera said a court has issued an order denying CareDx's motion for summary judgment on two patents in the infringement lawsuit filed against...

CareDx, Inc (NASDAQ:CDNA – Get Free Report) saw a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 3,890,000 shares, a decrease of 13.6% from the October 31st total of 4,500,000 shares. Based on an average trading volume of 957,600 shares, the short-interest ratio is […]